USPTO trademark

XOMIVI

Under examinationUSPTOWord markClass 5

"XOMIVI" is a word mark owned by Amgen Inc., filed at the USPTO on September 25, 2026. It is under examination and covers class 5 (Pharmaceuticals).

Official USPTO record
XOMIVI trademark as filed
As filed with the USPTO
Status
Under examination
Since October 27, 2026
Filed
September 25, 2026
Registered
Not yet
Expires
Not recorded
Application no.
50130174
Registration no.
Not yet
Office
USPTO
United States Patent and Trademark Office
Mark type
Word mark
1 class
Ownership

Who owns XOMIVI

The owner on file, matched to the company behind it. Every owner-name spelling for that company is grouped on its page.

Goods and services

What the mark covers

The products and services XOMIVI is filed for, grouped by Nice class.

  • Pharmaceutical and biological preparations for the prevention and treatment of obesity, cancer, osteoporosis, and inflammatory, autoimmune, cardiovascular, and blood diseases and disorders; Pharmaceutical and biological preparations for the prevention and treatment of metabolic, endocrine, musculoskeletal, cardiovascular, cardiometabolic, genitourinary, oncological, hepatological, ophthalmic, otolaryngological, respiratory, neurological, nephrological, hematological, hormonal, dermatological, and immune system-related diseases and disorders; Pharmaceutical preparations

History

What has happened so far

Steps recorded by the USPTO, newest first.

  1. Assigned to examiner
  2. Application filing receipt mailed
  3. New application office supplied data entered
  4. New application entered
FAQ

About XOMIVI

Who owns the trademark "XOMIVI"?

The USPTO trademark "XOMIVI" (application 50130174) is owned by Amgen Inc.

What is the status of "XOMIVI"?

Its status at the USPTO is: under examination.

API

Get this data via the API

Everything on this page comes from the Signa API. Pull XOMIVI and marks like it into your own product with one request.

  • GET/v1/trademarks/{id}

    The full record: owners, classes, dates and images

  • GET/v1/trademarks/{id}/events

    Every step in the office history

  • GET/v1/proceedings?trademark_id={id}

    Oppositions and cancellations against the mark

GET /v1/trademarks/{id}
ID=tm_01a0ddd7-d344-72cf-8975-a14fa356b0d2
curl https://api.signa.so/v1/trademarks/$ID \
  -H "Authorization: Bearer $SIGNA_API_KEY"
Response
{
  "id": "tm_01a0ddd7-d344-72cf-8975-a14fa356b0d2",
  "object": "trademark",
  "mark_text": "XOMIVI",
  "status": {
    "primary": "pending",
    "stage": "examining"
  },
  "office_code": "US",
  "application_number": "50130174",
  "filing_date": "2026-09-25",
  "nice_classes": [
    5
  ],
  "owners": [
    {
      "name": "Amgen Inc.",
      "entity_id": "ent_019eb6fb-7ab7-71bf-a46d-b0ba9848c4af"
    }
  ]
}